Decree No. 860 of 30 August 2016 expands the existing state intervention (Decree No. 1047 of 1 October 2015) for the promotion of the local production of medicines.Concretely, it will:

Subsidise projects for production of several pharmaceutical substances under a single contract for the provision of subsidies. Currently, it is possible to subsidise projects involving the production of only one substance. In addition, these projects should include the production of at least one pharmaceutical substance of a medicine included in the list of vital and essential medicinal products.

Create conditions for support of new organisations for the production of medicines that have not passed a licensing procedure;

Expand the project costs eligible for subsidisation to salaries of employees with higher pharmaceutical, medical, biological and chemical education and (or) doctoral degree and work experience in the area of development of medical products of at least 3 years.

The federal budget for 2016 foresees the allocation of 1.5 billion RUB (ca. 23.16 million USD) for the policy intervention. The subsidies are provided as part of the sub-programme "Development of medicines production" of the state program "Development of pharmaceutical and medical industry" for 2013--2020". Since Decree No. 860 plans the allocation of state subsidies in 2016 but does not allocate them, it is classified as amber.

The GTA includes state guarantees and other financial incentives that are likely to affect the restructuring and performance of firms facing international competition, whether from imports, in export markets and from foreign subsidiaries.

2936
Provitamins and vitamins, natural or reproduced by synthesis (including natural concentrates), derivatives thereof used primarily as vitamins, and intermixtures of the foregoing, whether or not in any solvent.

2940
Sugars, chemically pure, other than sucrose, lactose, maltose, glucose and fructose; sugar ethers, sugar acetals and sugar esters, and their salts, other than products of heading 29.37, 29.38 or 29.39.

294000
Sugars, chemically pure, other than sucrose, lactose, maltose, glucose and fructose; sugar ethers, sugar acetals and sugar esters, and their salts, other than products of heading 29.37, 29.38 or 29.39.

3001
Glands and other organs for organotherapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organotherapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or

3003
Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale.

3004
Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packin

300410
Containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivatives